Home » Blog » AIIMS Bhubaneswar Upgrades Three Advanced Laboratories to Boost Diagnostic Services in Odisha

AIIMS Bhubaneswar Upgrades Three Advanced Laboratories to Boost Diagnostic Services in Odisha

Bhubaneswar, Nov 17 (UDN): In a major boost to specialised diagnostic healthcare in Odisha, the All India Institute of Medical Sciences (AIIMS), Bhubaneswar, has inaugurated three upgraded laboratories under its Department of Biochemistry, expanding its capacity to provide advanced, accurate and affordable diagnostic services.

AIIMS Bhubaneswar Upgrades Three Advanced Laboratories to Boost Diagnostic Services in Odisha

The newly upgraded facilities include the Antenatal and New-born Screening Laboratory, Immunology Laboratory and High-Performance Liquid Chromatography (HPLC) Laboratory. Equipped with advanced diagnostic instruments and digital reporting systems, the laboratories are expected to improve early disease detection, enhance clinical decision-making and make specialised investigations more accessible to patients across Odisha and neighbouring states.

The facilities were inaugurated by AIIMS Bhubaneswar Executive Director and CEO Professor (Dr.) Ashutosh Biswas in the presence of Dean (Academic) Dr. Dillip Kumar Parida, Medical Superintendent Dr. Prabhas Ranjan Tripathy, and Dean (Examination) and Head of the Department of Biochemistry Dr. Manaswini Mangaraj.

Highlighting the significance of the upgraded infrastructure, Professor Biswas said the advanced diagnostic platform would enable the detection of extremely low concentrations of substances in samples such as urine and cerebrospinal fluid (CSF). He noted that such specialised testing capabilities were not currently available at any other government healthcare institution in Odisha.

Advanced Screening for New-borns and Expectant Mothers

The Antenatal and New-born Screening Laboratory has been equipped with a Revvity Victor 2D Fluorometer to improve the sensitivity and accuracy of screening tests.

Seven new-born screening parameters have been standardised and integrated with the Hospital Management Information System (HMIS), enabling online reporting of test results. The institute will also introduce screening for Phenylketonuria (PKU) and Cystic Fibrosis (CF) through Immunoreactive Trypsinogen (IRT) testing.

The facility will provide a comprehensive range of antenatal screening investigations, including dual-marker tests comprising free beta-hCG and PAPP-A, triple-marker tests incorporating unconjugated estriol, and penta-marker tests that include AFP and PlGF. Dedicated software will support risk prediction, helping clinicians assess potential pregnancy-related risks and plan appropriate interventions.

With these additions, AIIMS Bhubaneswar aims to strengthen early detection of congenital and pregnancy-related conditions through specialised screening services that are currently unavailable at other government healthcare institutions in the state.

Immunology Laboratory Expands Specialised Testing

The Immunology Laboratory has been upgraded with a Siemens Atellica NEPH 630 Nephelometer, significantly strengthening its capacity for specialised protein and immune-related investigations.

The laboratory is currently offering six important tests: Immunoglobulin G (IgG), IgA, IgM, IgE, Complement C3 and Complement C4. The system has been calibrated and integrated with HMIS to facilitate digital reporting.

The institute also plans to expand its diagnostic portfolio to include IgG subclasses, free light chains (kappa and lambda), Antistreptolysin O (ASO), Rheumatoid Factor (RF), Cystatin C, Homocysteine, Lipoprotein(a), Transferrin, soluble transferrin receptor, Haptoglobin, Hemopexin, C1 Esterase Inhibitor, Alpha-1 Antitrypsin, Ceruloplasmin and Beta-2 Microglobulin.

Additionally, lymphocyte cross-matching services will be introduced to support patients undergoing solid organ transplantation, adding another important dimension to the institute’s specialised diagnostic and transplant-related services.

AIIMS First to Procure High-Throughput HPLC Analyser

Another major highlight is the upgraded HPLC Laboratory, which will strengthen testing for glycated haemoglobin (HbA1c), a key investigation used in the diagnosis and long-term monitoring of diabetes.

High-Performance Liquid Chromatography is widely recognised as a gold-standard methodology for HbA1c analysis. AIIMS Bhubaneswar has become the first AIIMS institution to procure this high-throughput analyser, marking an important milestone in its diagnostic infrastructure.

The advanced system is expected to enhance testing capacity and support reliable diabetes-related investigations, benefiting patients requiring routine monitoring as well as specialised clinical assessment.

Strengthening Odisha’s Diagnostic Healthcare Infrastructure

The inauguration of the three upgraded laboratories represents an important step in AIIMS Bhubaneswar’s efforts to expand access to specialised diagnostic facilities within the state.

By introducing advanced screening technologies, expanding immunological investigations and strengthening diabetes testing capabilities, the institute aims to improve diagnostic accuracy and facilitate timely clinical intervention.

The enhanced infrastructure is also expected to reduce patients’ dependence on diagnostic centres outside Odisha for specialised investigations, making advanced healthcare more accessible and affordable.

With these developments, AIIMS Bhubaneswar is further reinforcing its role as a major referral centre for advanced diagnostic and tertiary healthcare services in eastern India.

Leave a Reply

Your email address will not be published. Required fields are marked *